Tandem Diabetes Care (TNDM) Return on Capital Employed Growth (1y) (2015 - 2026)
Tandem Diabetes Care (TNDM) Return on Capital Employed Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -1,390.00 |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -110.00 |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 658.00 |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -3,185.00 |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 125.00 |
| 10 | Tandem Diabetes Care | 1.17 Bn | 597.96 Mn | 136.79 Mn | 1,626.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,626.00 |
| Dec 31, 2025 | -1,563.00 |
| Sep 30, 2025 | -1,209.00 |
| Jun 30, 2025 | -1,090.00 |
| Mar 31, 2025 | -764.00 |
| Dec 31, 2024 | 1,720.00 |
| Sep 30, 2024 | 915.00 |
| Jun 30, 2024 | 999.00 |
| Mar 31, 2024 | 516.00 |
| Dec 31, 2023 | -2,056.00 |
| Sep 30, 2023 | -2,138.00 |
| Jun 30, 2023 | -2,909.00 |
| Mar 31, 2023 | -2,594.00 |
| Dec 31, 2022 | -1,353.00 |
| Sep 30, 2022 | -1,124.00 |
| Jun 30, 2022 | -378.00 |
| Mar 31, 2022 | 90.00 |
| Dec 31, 2021 | 438.00 |
| Sep 30, 2021 | 860.00 |
| Jun 30, 2021 | 1,104.00 |